A kind of pharmaceutical composition of amoxicillin sodium clavulanate potassium compound
A technology of amoxicillin sodium clavulanate potassium and amoxicillin sodium is applied in the field of pharmaceutical compositions of amoxicillin sodium clavulanate potassium compounds, and can solve the problems of poor stability of amoxicillin sodium clavulanate potassium and the like, Achieve the effect of ensuring efficacy and safety, improving stability and rapid dissolution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] Example 1 Preparation of Amoxicillin Sodium Clavulanate Potassium (4:1) Suspension Powder Injection
[0016] Prescription (200 bottles):
[0017] Amoxicillin sodium 100g;
[0018] Potassium clavulanate 25g;
[0019] Sodium octanoate 12.5g;
[0020] Glycine 12.5g;
[0021] Trehalose 30g.
[0022] Preparation
[0023] Under the protection of an inert gas, dissolve amoxicillin sodium, potassium clavulanate, trehalose, sodium octanoate and glycine with 2000ml of water for injection, add 10g of activated carbon for needles, stir for 30min, and filter to remove carbon; use a 0.22μm microporous membrane Sterile filtration, filling, semi-tamponing, and freeze-drying to obtain amoxicillin sodium clavulanate potassium suspension powder injection.
Embodiment 2
[0024] Example 2 Preparation of Amoxicillin Sodium Clavulanate Potassium (4:1) Suspension Powder Injection
[0025] Prescription (400 bottles):
[0026] Amoxicillin sodium 200g;
[0027] Potassium clavulanate 50g;
[0028] Sodium octanoate 25g;
[0029] Glycine 25g;
[0030] Trehalose 60g.
[0031] Preparation
[0032] Under the protection of an inert gas, dissolve amoxicillin sodium, potassium clavulanate, trehalose, sodium octanoate and glycine with 4000ml of water for injection, add 10g of activated carbon for needles, stir for 30min, and filter to remove carbon; use a 0.22μm microporous membrane Sterile filtration, filling, semi-tamponing, and freeze-drying to obtain amoxicillin sodium clavulanate potassium suspension powder injection.
Embodiment 3
[0033] Embodiment 3 long-term stability test
[0034] Batch number 1: 459630 Batch size: 1000 bottles Specification: 0.6g / bottle Packaging: vials
[0035] Inspection conditions: 25±2℃ / 60±10%RH
[0036]
[0037] Through the long-term stability test, it can be found that the amoxicillin sodium and clavulanate potassium composition of the present invention has good stability during preparation and storage, which ensures the curative effect and safety of clinical use.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

